GlobeNewswire·Apr 20, 2026, 8:00 AM ET

Nanox Announces Fourth Quarter of 2025 Financial Results and Provides Business Updates

NNOX

Nanox Imaging reported Q4 2025 revenue of $3.7 million, up from $3.0 million in the prior year quarter.
The company posted a Q4 2025 net loss of $33.4 million, largely driven by a $17.5 million non-cash impairment charge related to restructuring its South Korean semiconductor facility.
Nanox completed the acquisition of Vaso Healthcare IT Corp., rebranded as Nanox Health IT, which contributed $0.4 million to Q4 revenue.
A new distribution agreement was signed with Howard Technology Solutions to deploy 300 Nanox.ARC systems across the U.S. over three years.
Total Capex system distribution agreements executed amount to approximately 360 systems in the U.S. over the next two to three years.
Approximately 36 Nanox.ARC systems are currently in various stages of deployment, with an additional 17 systems expected to be installed soon under the Nanox Imaging Network initiative.
The company initiated a restructuring of its South Korean manufacturing operations to transition from company-owned to an outsourced model, with total restructuring charges estimated at $18.0 million.
Guy Nathanzon was appointed as the new Chief Financial Officer effective August 1, 2026, succeeding Ran Daniel who is stepping down on July 31, 2026.
The company maintained its full-year 2026 revenue guidance of $35 million, contingent on system activations and deployment progress.
As of December 31, 2025, the company held $60.0 million in cash, cash equivalents, and marketable securities, down from $83.5 million the previous year.
Cedars Sinai was added as a clinical trial partner to evaluate the Nanox.AI aortic valve calcification solution.
The company noted no material operational disruptions from the geopolitical situation in the Middle East as of the report date but continues to monitor the dynamic environment.